GOLGA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.809700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.762400E-01
Normal-vs-Stage2
6.656100E-02
Normal-vs-Stage3
1.656290E-02
Normal-vs-Stage4
2.614400E-01
Stage1-vs-Stage2
1.724050E-01
Stage1-vs-Stage3
2.428400E-02
Stage1-vs-Stage4
5.142400E-01
Stage2-vs-Stage3
1.589910E-02
Stage2-vs-Stage4
8.598000E-01
Stage3-vs-Stage4
3.814100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.057030E-01
Normal-vs-AfricanAmerican
8.259600E-02
Normal-vs-Asian
2.303600E-01
Caucasian-vs-AfricanAmerican
5.681800E-01
Caucasian-vs-Asian
7.717800E-01
AfricanAmerican-vs-Asian
4.987400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.340400E-02
Normal-vs-Female
1.484810E-01
Male-vs-Female
4.440800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.498600E-01
Normal-vs-Age(41-60Yrs)
2.210800E-01
Normal-vs-Age(61-80Yrs)
6.620200E-02
Normal-vs-Age(81-100Yrs)
1.108210E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.775600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.716200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.653200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.308000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.680600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.517400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.281720E-02
Normal-vs-Daily Drinker
2.197800E-01
Normal-vs-Weekly Drinker
1.728600E-01
Normal-vs-Occasional Drinker
5.847800E-02
Normal-vs-Social Drinker
7.439200E-01
Non Drinker-vs-Daily Drinker
1.146390E-01
Non Drinker-vs-Weekly Drinker
1.047230E-01
Non Drinker-vs-Occasional Drinker
3.108000E-01
Non Drinker-vs-Social Drinker
9.881000E-03
Daily Drinker-vs-Weekly Drinker
9.599600E-01
Daily Drinker-vs-Occasional Drinker
5.622400E-01
Daily Drinker-vs-Social Drinker
1.374180E-01
Weekly Drinker-vs-Occasional Drinker
5.106000E-01
Weekly Drinker-vs-Social Drinker
1.691620E-01
Occasional Drinker-vs-Social Drinker
3.890100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.802160E-01
Normal-vs-Grade 2
3.191600E-02
Normal-vs-Grade 3
4.501700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.402800E-01
Grade 1-vs-Grade 3
7.500600E-01
Grade 1-vs-Grade 4
1.802160E-01
Grade 2-vs-Grade 3
8.125400E-01
Grade 2-vs-Grade 4
3.191600E-02
Grade 3-vs-Grade 4
4.501700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.775700E-02
Normal-vs-NonDiabetic
1.278390E-01
Diabetic-vs-NonDiabetic
9.553700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.971960E-01
Normal-vs-NoPancreatitis
7.273700E-02
Pancreatitis-vs-NoPancreatitis
5.173600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.872440E-01
Normal-vs-N1
6.771600E-02
N0-vs-N1
4.700400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.189600E-01
Normal-vs-TP53-NonMutant
5.350800E-01
TP53-Mutant-vs-TP53-NonMutant
3.868000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
